Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?
Volume 39 - Issue 3 - September 2024, Page 368-374
Meltem Alkan Melikoğlu

Enter the code above.